2027 9th International Conference on Biotechnology and Biomedicine (ICBB 2027) will be held in Changsha, Hunan, China, from February 26 to 28, 2027.
Biotechnology is a rapidly evolving field with far-reaching implications for human life, disease management, and healthcare. It plays a pivotal role in modern medicine while directly accelerating the advancement of related industries, including medical devices and pharmaceutical materials. Since its inception in 2019, the International Conference on Biotechnology and Biomedicine (ICBB) has been successfully held in Guizhou, Qingdao, Dali, Nanjing, Wuhan, and Guangzhou. The conference has established itself as a premier international academic platform, bringing together experts, professors, scholars, engineers, physicians, and professionals from universities, research institutions, and enterprises worldwide. It offers a unique opportunity for participants to share specialized knowledge, expand professional networks, exchange innovative ideas face-to-face, and showcase their latest research achievements.
ICBB 2027 aims to address key challenges and explore emerging research directions in biotechnology and biomedicine, thereby fostering the advancement and application of theoretical and technological innovations in both academia and industry. The conference also facilitates the establishment of meaningful professional connections and future collaborative partnerships. Esteemed experts and scholars from around the globe will gather to engage in in-depth technical discussions on cutting-edge topics, contributing significantly to the advancement of knowledge in these rapidly evolving scientific domains. Attendees will not only benefit from insightful presentations delivered by leading experts but also have the opportunity to engage in direct dialogue and collaborative exploration.
Full Paper Submission Date: January 10, 2027
Registration Deadline: January 25, 2027
Final Paper Submission Date: January 31, 2027
Conference Dates: February 26–28, 2027
Submit to Conference Proceedings (EI)
All accepted full papers will be published in the conference proceedings and will be submitted to Scopus, CNKI for indexing.
Note: All submitted articles should report original research results, experimental or theoretical, not previously published or under consideration for publication elsewhere. Articles submitted to the conference should meet these criteria. We firmly believe that ethical conduct is the most essential virtue of any academics. Hence, any act of plagiarism or other misconduct is totally unacceptable and cannot be tolerated.
 | ||